Astrana Health, Inc. (NASDAQ:ASTH) Sees Significant Decrease in Short Interest

Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) saw a large decline in short interest during the month of February. As of February 28th, there was short interest totalling 1,440,000 shares, a decline of 23.0% from the February 13th total of 1,870,000 shares. Based on an average daily volume of 346,500 shares, the days-to-cover ratio is presently 4.2 days. Currently, 3.9% of the company's stock are sold short.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the company. Macquarie upgraded Astrana Health to a "hold" rating in a report on Monday, December 16th. Truist Financial lowered their price target on Astrana Health from $50.00 to $46.00 and set a "buy" rating for the company in a report on Tuesday. Robert W. Baird lowered their price target on Astrana Health from $86.00 to $50.00 and set an "outperform" rating for the company in a report on Monday, March 3rd. Stifel Nicolaus lowered their price target on Astrana Health from $70.00 to $56.00 and set a "buy" rating for the company in a report on Thursday, February 20th. Finally, Bank of America lowered their price target on Astrana Health from $55.00 to $49.00 and set a "buy" rating for the company in a report on Tuesday, March 4th. Two equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Astrana Health has a consensus rating of "Moderate Buy" and a consensus price target of $56.17.

Remove Ads

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Pilgrim Partners Asia Pte Ltd bought a new position in Astrana Health during the fourth quarter valued at about $40,000. Quarry LP boosted its stake in Astrana Health by 35.5% during the fourth quarter. Quarry LP now owns 1,799 shares of the company's stock valued at $57,000 after buying an additional 471 shares in the last quarter. KBC Group NV bought a new position in Astrana Health during the third quarter valued at about $70,000. Quest Partners LLC bought a new position in Astrana Health during the third quarter valued at about $133,000. Finally, US Bancorp DE boosted its stake in Astrana Health by 3,880.0% during the fourth quarter. US Bancorp DE now owns 4,776 shares of the company's stock valued at $151,000 after buying an additional 4,656 shares in the last quarter. Institutional investors and hedge funds own 52.77% of the company's stock.

Astrana Health Stock Performance

NASDAQ:ASTH traded down $0.87 during midday trading on Thursday, reaching $30.65. 138,119 shares of the company traded hands, compared to its average volume of 251,507. Astrana Health has a twelve month low of $23.12 and a twelve month high of $63.20. The firm has a market capitalization of $1.72 billion, a price-to-earnings ratio of 23.47, a price-to-earnings-growth ratio of 1.37 and a beta of 1.30. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91. The company has a fifty day moving average price of $33.96 and a 200 day moving average price of $42.76.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.22 by ($0.37). Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The company had revenue of $665.21 million for the quarter, compared to analyst estimates of $617.24 million. On average, analysts expect that Astrana Health will post 1.15 EPS for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.